vaccine

A man receives a H1N1 swine flu vaccine at XXXXX on October 27, 2009 in Seoul, South Korea. The Korea Food and Drug Administration approved domestically developped vaccines last week, the government plan to vaccinate 35 percent of South Korean population until next February.
A man receives a H1N1 swine flu vaccine at XXXXX on October 27, 2009 in Seoul, South Korea. The Korea Food and Drug Administration approved domestically developped vaccines last week, the government plan to vaccinate 35 percent of South Korean population until next February.
WINSTON SALEM, NC - SEPTEMBER 08: President Donald Trump addresses a crowd during a campaign rally at Smith Reynolds Airport on September 8, 2020 in Winston Salem, North Carolina. The president also made a campaign stop in South Florida on Tuesday. (Photo by Sean Rayford/Getty Images)
Federal Government Details Audacious Plan To Distribute COVID Vaccine In Coming Months
By RICARDO ALONSO-ZALDIVAR | September 16, 2020 9:39 a.m.
Vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, rest on a lab table at the Kaiser Permanente Washington Health Research Institute in Seattle on Monday, March 16, 2020. (AP Photo/Ted S. Warren)
Keep An Eye On This Prime Badge
By | September 4, 2020 3:57 p.m.
FILE In this file photo taken on Thursday, July 9, 2020, Russian President Vladimir Putin gestures during a video conference meeting at the Novo-Ogaryovo residence outside Moscow in Moscow, Russia. Putin says that a coronavirus vaccine developed in the country has been registered for use and one of his daughters has already been inoculated. Speaking at a government meeting Tuesday, Putin said that the vaccine has proven efficient during tests, offering a lasting immunity from the coronavirus. (Alexei Druzhinin, Sputnik, Kremlin Pool Photo via AP, File)
Russia Approves Coronavirus Vaccine Despite Intense International Skepticism
By VLADIMIR ISACHENKOV | August 11, 2020 9:17 a.m.
Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for the COVID-19 coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Browning is the second patient to receive the shot in the study. (AP Photo/Ted S. Warren)
Vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, rest on a lab table at the Kaiser Permanente Washington Health Research Institute in Seattle on Monday, March 16, 2020. (AP Photo/Ted S. Warren)
Major COVID-19 Vaccine Trial Gets Underway With 30,000 Volunteers
By Lauran Neergaard, | July 27, 2020 7:38 a.m.
Early Trial Of Coronavirus Vaccine In UK Shows Positive Results
By MARIA CHENG | July 20, 2020 10:31 a.m.
Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for the COVID-19 coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Browning is the second patient to receive the shot in the study. (AP Photo/Ted S. Warren)
US, UK And Canada Accuse Russia Of Trying To Steal COVID-19 Vaccine Info
By JILL LAWLESS and Danica Kirka | July 16, 2020 9:36 a.m.
Early Coronavirus Vaccine Results Show Promise
By Associated Press | May 18, 2020 10:51 a.m.
European Leaders Tell Citizens To Steel Themselves For Life Without COVID Vaccine
By COLLEEN BARRY, PABLO GORONDI and KELVIN CHAN | May 17, 2020 10:02 a.m.
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Senior Editor:
Special Projects Editor:
Investigations Desk:
Reporters:
Newswriters:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front-End Developer:
Senior Designer:
SPECIAL DEAL FOR PAST TPM MEMBERS
40% OFF AN ANNUAL PRIME MEMBERSHIP
REJOIN FOR JUST $30
REJOIN FOR JUST $30